LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。


As Drug Supply Chain Security Act (DSCSA) interoperability takes full effect, Global Location Numbers (GLNs) have become essential for accurate EPCIS data exchange and verifiable chain-of-custody records. GLNs identify where events occur, who is responsible for a shipment, and which trading partners are involved in serialized transactions.
This post explores how GLNs function inside EPCIS events, how they support DSCSA compliance, and why pharmacies need them for both dispensing and distribution activities.
Every Electronic Product Code Information Services (EPCIS) event must identify the physical and business locations involved. GLNs appear in:
Commissioning, shipping, receiving, packing, and decommissioning events all depend on GLNs to ensure trading partners can link physical movements to compliance records.
Although both fields use GLNs, they serve different purposes:
Correctly assigning GLNs to these fields is crucial for preventing EPCIS mismatches and ensuring DSCSA compliance.
Even as EPCIS becomes the standard for serialized data exchange, DSCSA’s Transaction Information (TI) and Transaction Statement (TS) still rely on GLNs to identify:
Incomplete or incorrect GLNs in TI/TS records create regulatory gaps and complicate audits.
DSCSA requires pharmacies and other entities to transact only with authorized trading partners. GLNs help confirm:
A GLN functions like a universally understood ID number, removing ambiguity in compliance records.
GLNs make serialized traceability possible by establishing a clear trail of:
During audits, regulators depend on GLNs to verify the accuracy and completeness of DSCSA data. Missing or misused GLNs can break the traceability chain and trigger compliance findings.
Pharmacies use GLNs to validate inbound EPCIS data from wholesalers and manufacturers so that they can be dispensed.
Correct GLNs ensure that serialized products are shipped to the correct location and recorded accurately in compliance systems.
Any outbound transfer — including Loan & Borrow, inter-store replenishment, clinic supply, or emergency transfers (unless within the same legal ownership) — requires outbound EPCIS.
Outbound EPCIS cannot be generated without:
This makes GLNs essential not just for receiving product, but for any pharmacy engaging in distribution activities.
Regulators expect pharmacies to:
Incorrect GLNs are treated as compliance gaps within DSCSA traceability.
GLNs allow pharmacies and their partners to identify each other with precision in:
Using GLNs properly reduces misalignment between partners and prevents EPCIS rejection events—one of the most common issues in DSCSA compliance today—and the quarantine that results.
GLNs are the backbone of DSCSA compliance. They identify the physical and business locations involved in serialized events, support EPCIS accuracy, validate trading partners, and ensure pharmacies maintain a complete chain-of-custody record. Whether receiving or distributing regulated product, pharmacies must implement and correctly apply GLNs to remain compliant in the modern, interoperable drug supply chain.
Want to learn more about GLNs? Explore the related articles in our blog series to dive deeper into how GLNs work, why they matter, and how they’re used across the supply chain.